Sarcopenia and outcomes after CRS ± HIPEC for gastric peritoneal metastases: no association with major morbidity and poorer survival in synchronous disease.
INTRODUCTION We evaluated whether computed tomography (CT)-based body composition parameters predict outcomes after hyperthermic intraperitoneal chemotherapy (CRS ± HIPEC) for gastric peritoneal metastases (GPM). METHODS A retrospective analysis of a prospectively maintained single-centre database included consecutiv...